Science
Mechanism of Action
Functioning as Quaternium-73, this ingredient exerts its effects by disrupting bacterial cell membranes, leading to their degeneration and accelerating acne resolution. It demonstrates significant inhibitory action against Propionibacterium acnes, the primary bacteria involved in acne vulgaris. Concurrently, it interferes with melanin synthesis, contributing to a visibly brighter complexion and helping to reduce the appearance of dark spots.
Research
Clinical Evidence
High confidence0.001%
Key findings
- 01 Demonstrated efficacy in killing bacteria and fungi, leading to improved acne symptoms.
- 02 Achieved Minimum Inhibitory Concentration (MIC) against Bacillus acnes at an extremely low level.
- 03 Completely inhibited melanin formation and suppressed 83% of melanin formation in vitro.
- 04 Suppressed 50% melanin formation in vitro at a trace concentration.
Transparency
Dusting Analysis
This ingredient exhibits profound efficacy at incredibly low concentrations, with effects like 50% melanin suppression observed at 0.000003% and complete melanin inhibition at 0.00001%. While some recommended usage ranges for general skincare extend up to 0.005%, exceeding 0.001% is likely an over-formulation for its primary benefits and may introduce a risk of mild irritation, despite higher concentrations (up to 0.2%) showing no irritation in isolated patch tests. Therefore, concentrations significantly above 0.001% should be critically evaluated for genuine therapeutic intent.
The Formula
Formulation
Stability
This compound is sensitive to light, necessitating opaque packaging for finished products to maintain integrity. It exhibits robust thermal stability up to 85°C. For optimal integration, it is advisable to pre-dissolve the ingredient in polyols such as butylene glycol, propylene glycol, ethanol, or 1,2-pentanediol before incorporation into formulations. It is compatible across a wide spectrum of product types, including water-based solutions, essences, gels, masks, creams, and lotions.
Safety
Safety Profile
Extensive safety assessments, including human body patch tests at 0.2% and various animal studies (initial/sustained skin irritation, eye irritation, skin sensitization, phototoxicity, photosensitization), consistently indicate negative irritation or sensitization results at these tested levels. Gene mutation tests (Ames test) also yielded negative results. Environment Canada has classified it as not expected to be potentially toxic or harmful, nor suspected to be persistent, bioaccumulative, or an environmental toxin. Acute toxicity studies (LD50 mouse 325 mg/kg; LD50 oral rat 460 mg/kg) confirm a low acute risk. However, it's noted that concentrations above typically 0.0001% to 0.001% may lead to mild irritation, hence our recommendation for a conservative maximum usage for daily application.
Your Skin
Skin Compatibility
Our Assessment
Verdict
This highly potent compound is a valuable asset for targeted treatment of acne and hyperpigmentation, delivering significant results at extremely low, precise concentrations, provided formulation respects its sensitivity and optimal usage.
Related
Similar Ingredients
Finding similar ingredients…